Work

Supplementary Data 2 from Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Year: 2023

Type: supplementary-materials

DOI: 10.1158/1078-0432.22479044

Authors: Zhi Peng, Jia Wei, Feng Wang, Jieer Ying, Yanhong Deng, Kangsheng Gu, Ying Cheng, Xianglin Yuan, Juxiang Xiao, Yanfei Tai, Linna Wang, Jianjun Zou, Yanqiao Zhang, Lin Shen

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361938566

Cites:

Cited by:

Related to: 10